Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Maintenance avelumab plus best supportive care (BSC) versus BSC alone after chem...
Prof Thomas Powles - Barts Cancer Institute, London, UK
Maintenance avelumab plus best supportive care (BSC) versus BSC alone after chemotherapy in advanced urothelial carcinoma ( Prof Thomas Powles -  Barts Cancer Institute, London, UK )
29 May 2020
Brigatinib for NSCLC, latest research and overcoming complications
Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA
Brigatinib for NSCLC, latest research and overcoming complications ( Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA )
29 May 2020
Sym015 shows superior specificity compared to TKIs for NSCLC
Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA
Sym015 shows superior specificity compared to TKIs for NSCLC ( Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA )
29 May 2020
CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell th...
Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy for r/r multiple myeloma ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
29 May 2020
Better genetic diagnostics in Ugandan breast cancer patients
Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA
Better genetic diagnostics in Ugandan breast cancer patients ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )
29 May 2020
ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer
Prof Roy Herbst - Yale Cancer Center, New Haven, USA
ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer ( Prof Roy Herbst - Yale Cancer Center, New Haven, USA )
29 May 2020
Conducting Oncology Clinical Trials in Africa II: AC3T - Assessing, profiling, a...
Daniel Seymour - BIO Ventures for Global Health, Seattle, USA
Conducting Oncology Clinical Trials in Africa II: AC3T - Assessing, profiling, and building cancer clinical trial capacity in Africa ( Daniel Seymour - BIO Ventures for Global Health, Seattle, USA )
27 May 2020
Perioperative use of NSAIDs reduces risk of early relapse in breast cancer
Dr Michael Retsky - Harvard T.H. Chan School of Public Health, Boston, USA
Perioperative use of NSAIDs reduces risk of early relapse in breast cancer ( Dr Michael Retsky - Harvard T.H. Chan School of Public Health, Boston, USA )
26 May 2020
Do immune checkpoint inhibitors work in EGFR mutant lung cancer?
Dr Edward Garon - UCLA Medical Center, Santa Monica, USA
Do immune checkpoint inhibitors work in EGFR mutant lung cancer? ( Dr Edward Garon - UCLA Medical Center, Santa Monica, USA )
22 May 2020
Diagnosing, treating and managing breast cancer during COVID-19
Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium
Diagnosing, treating and managing breast cancer during COVID-19 ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )
22 May 2020
IMPRIME 1: Combination of pembrolizumab and a novel innate immune activator, Imp...
Dr Steven O'Day - John Wayne Cancer Institute, Santa Monica, USA
IMPRIME 1: Combination of pembrolizumab and a novel innate immune activator, Imprime PGG, in second-line mTNBC ( Dr Steven O'Day - John Wayne Cancer Institute, Santa Monica, USA )
19 May 2020
Concomitant use of antibiotics and immune checkpoint inhibitors in patients with...
Dr Akhil Kapoor - Tata Memorial Center, Mumbai, India
Concomitant use of antibiotics and immune checkpoint inhibitors in patients with solid neoplasms ( Dr Akhil Kapoor - Tata Memorial Center, Mumbai, India )
15 May 2020